Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
2017
Anti-HIV-1 neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
149
References
9
Citations
NaN
KQI